MBXBF Stock - Microbix Biosystems Inc.
Unlock GoAI Insights for MBXBF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $13.34M | $25.39M | $16.51M | $19.08M | $18.59M |
| Gross Profit | $7.07M | $15.39M | $7.48M | $11.12M | $11.04M |
| Gross Margin | 53.0% | 60.6% | 45.3% | 58.3% | 59.4% |
| Operating Income | $-1,131,678 | $3.91M | $-2,736,432 | $2.69M | $4.84M |
| Net Income | $-1,612,493 | $3.52M | $-39,483 | $1.79M | $1.63M |
| Net Margin | -12.1% | 13.9% | -0.2% | 9.4% | 8.8% |
| EPS | $-0.01 | $0.03 | $-0.00 | $0.01 | $0.01 |
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. The company also applies its biological expertise and infrastructure to develop other proprietary products, primarily viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic Urokinase, a biologic thrombolytic drug used to treat blood clots. It sells QAPs to lab accreditation organizations, diagnostics companies, and clinical labs through a network of regional distributors. Microbix Biosystems Inc. was founded in 1988 and is headquartered in Mississauga, Canada.
Visit WebsiteEarnings History & Surprises
MBXBFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 13, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Dec 18, 2025 | — | $-0.01 | — | — |
Q3 2025 | Aug 14, 2025 | — | $-0.01 | — | — |
Q2 2025 | May 13, 2025 | — | $0.00 | — | — |
Q1 2025 | Feb 12, 2025 | — | $0.00 | — | — |
Q3 2024 | Sep 30, 2024 | — | $0.00 | — | — |
Q3 2024 | Aug 7, 2024 | — | $0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $0.00 | — | — |
Q1 2024 | Feb 14, 2024 | — | $0.01 | — | — |
Q3 2023 | Sep 30, 2023 | — | $0.01 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 16, 2023 | $-0.00 | $-0.00 | +70.9% | ✓ BEAT |
Q1 2023 | Feb 9, 2023 | $-0.00 | $-0.01 | -549.4% | ✗ MISS |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 11, 2022 | $0.00 | $0.00 | -20.0% | ✗ MISS |
Q2 2022 | May 12, 2022 | $0.02 | $0.01 | -58.3% | ✗ MISS |
Q4 2021 | Dec 23, 2021 | $0.01 | $0.01 | +11.1% | ✓ BEAT |
Q3 2021 | Sep 30, 2021 | — | $0.00 | — | — |
Q3 2021 | Aug 12, 2021 | $0.01 | $0.01 | +57.2% | ✓ BEAT |
Frequently Asked Questions about MBXBF
What is MBXBF's current stock price?
What is the analyst price target for MBXBF?
What sector is Microbix Biosystems Inc. in?
What is MBXBF's market cap?
Does MBXBF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MBXBF for comparison